ChinaPeptides: difference between revisions
Diff·revision 46 → 47·10:42, 9 Jul 2025
Difference between revision 46 and revision 47 of ChinaPeptides. 7 lines changed; the page grew by 783 bytes.
| Revision 46 — 14:05, 2 Jul 2025 SecondarySrc_Seb (talk) restructure 9,088 bytes +810 | Revision 47 — 10:42, 9 Jul 2025 BatchNumberBede (talk) add citation for the incidence figure 9,871 bytes +783 | ||
|---|---|---|---|
| 61 | The PeptidePedia tally records 902 self-reported submissions to July 2026. Recurring positive themes are custom-synthesis execution and mass-confirmation documentation; recurring complaints concern lead times and the two-name confusion.{{r|tally}} Self-selected; reception rather than quality.{{r|tally}} | 61 | The PeptidePedia tally records 902 self-reported submissions to July 2026. Recurring positive themes are custom-synthesis execution and mass-confirmation documentation; recurring complaints concern lead times and the two-name confusion.{{r|tally}} Self-selected; reception rather than quality.{{r|tally}} |
| 62 | 62 | ||
| + | 63 | === How this tally should be read === | |
| + | 64 | The reception figure above is a mean of self-reported submissions to PeptidePedia. It is '''weak evidence''' and is subject to three limitations that apply to every such figure on this wiki: | |
| + | 65 | ||
| + | 66 | * '''Self-selection.''' People who submit are not a sample of purchasers. Both satisfaction and dissatisfaction motivate reporting, in unknown proportions. | |
| + | 67 | * '''It measures reception, not quality.''' Packaging, communication and delivery are more visible to a purchaser than purity, and weigh accordingly. | |
| + | 68 | * '''It is not comparable across communities.''' Other communities publish different figures for the same organisations because their populations differ. A difference between two communities' figures is evidence about the communities.{{r|tally}} | |
| + | 69 | ||
| 63 | == Regulatory position and legal status == | 70 | == Regulatory position and legal status == |
| 64 | The organisation is a commercial entity registered in the People's Republic of China. Nothing in the available record indicates a manufacturing authorisation, marketing authorisation or pharmacopoeial registration in any jurisdiction, and none should be inferred from a registered business scope, which is a licensing fact and not a quality assurance.{{r|registry}} | 71 | The organisation is a commercial entity registered in the People's Republic of China. Nothing in the available record indicates a manufacturing authorisation, marketing authorisation or pharmacopoeial registration in any jurisdiction, and none should be inferred from a registered business scope, which is a licensing fact and not a quality assurance.{{r|registry}} |